This resolution designates the week of January 25-31, 2026, as "National School Choice Week" to recognize educational options for K-12 students. It encourages parents to learn about school choices and urges the public to host events raising awareness about diverse education environments, including public schools, charter schools, private schools, and homeschooling. The resolution has no policy or funding impact - it is a ceremonial designation acknowledging existing annual events celebrating educational choice.
The SAVE Moms and Babies Act of 2026 prohibits the FDA from approving new abortion drugs or granting investigational exemptions for them. It requires existing approved abortion drugs to be dispensed only in-person by certified healthcare providers in clinics or hospitals (not pharmacies), mandates providers to verify pregnancy duration and handle complications, and enforces strict adverse event reporting to the FDA. The bill directly affects healthcare providers prescribing abortion drugs, patients seeking these medications, and the FDA’s regulatory authority over such drugs. Key provisions include banning use after 70 days gestation, requiring provider certification for specific medical capabilities, and mandating documentation of risks to patients.
This bill removes age restrictions preventing working adults with disabilities from accessing Medicaid buy-in programs. It modifies the Social Security Act to eliminate the "less than 65" requirement, allowing individuals aged 16 and older who earn above Supplemental Security Income (SSI) limits but would otherwise qualify for SSI to enroll in Medicaid buy-in programs. The key change ensures states can provide Medicaid coverage to this group without age barriers, directly affecting working adults with disabilities who previously faced eligibility cutoffs at age 65. The bill also provides a transition period for states already offering similar programs, requiring no changes before January 1, 2028.
S 3627, the Pregnant Students’ Rights Act, requires colleges and universities participating in federal student aid programs to provide clear information about pregnancy-related resources and accommodations to all enrolled students. The bill mandates annual email notifications, inclusion in student handbooks and orientations, and availability at health centers and websites, detailing campus/community resources, available accommodations, and how to file Title IX complaints. It specifically covers students planning to or currently pregnant who wish to carry a baby to term. The law focuses solely on disseminating existing information and does not create new rights or accommodations. (Bill text amended under Section 485 of the Higher Education Act.)
S 3674, the Stop Citizenship Abuse and Misrepresentation Act (SCAM Act), expands grounds for revoking U.S. citizenship (denaturalization) for naturalized citizens who commit specific offenses within 10 years of becoming citizens. It targets individuals convicted of fraud against government programs (over $10,000), affiliation with foreign terrorist organizations, or certain aggravated felonies/espionage offenses, treating these as proof they lacked required moral character, loyalty to the Constitution, and commitment to U.S. order at the time of naturalization. If enacted, convictions would automatically trigger revocation of citizenship, treating the naturalization as void from the original date and making the person subject to deportation. The bill directly affects naturalized citizens who commit these offenses within the 10-year window, with no requirement for new evidence of pre-naturalization misconduct.
This bill requires providers receiving federal funds to provide detailed, FDA-approved drug warnings about chemical abortions to patients at least 24 hours before the procedure. It mandates that providers highlight warnings and adverse reactions from the drug label, read them to patients, and obtain written confirmation. Non-compliant providers risk losing federal funding, and patients can sue for damages if providers fail to follow these requirements. The law specifically excludes medical emergencies like ectopic pregnancies or miscarriage treatment from its definition of "chemical abortion."
HR 7235, the "Protecting Motherhood Act," requires all federal agencies to stop using the term "birthing person" in official documents and instead use specific terms like "female," "mother," "pregnant woman," or "woman." It directly affects federal agencies that produce regulations, forms, or communications, mandating the use of these defined terms when referring to individuals based on biological sex. The bill provides detailed definitions for terms like "female" (based on biological sex at conception) and "pregnant woman" (an adult human female carrying a child). The law takes effect 30 days after enactment. This is a procedural change focused solely on terminology in government documents, with no direct impact on healthcare access or services.
This bill creates a tax credit for businesses selling products made with U.S.-grown cotton. The credit equals 24% of the cotton's market value if processed only in the U.S. or in countries with U.S. trade deals, or 18% for other processing locations. To qualify, cotton must be digitally traced from U.S. farms to finished products and certified by the USDA as meeting origin requirements. It directly affects clothing and textile manufacturers selling qualifying products in the U.S. market.
HR 7206, the Farm and Family Relief Act, provides direct financial assistance to agricultural producers facing market challenges during the 2025 crop year. It establishes one-time payments for eligible crop producers (including wheat, corn, soybeans, and cotton) when expected costs exceed expected returns, with payment limits based on farming income (capping at $125,000 or $250,000 depending on farming income percentage). The bill allocates $5 billion for specialty crop producers, $500 million for timber industry assistance, and $330 million for sugar beet producers through cooperative block grants. Additionally, it delays certain cost-shift provisions in food assistance programs and terminates specific tariff-imposing executive orders.
HR 7199, the Gerald’s Law Act, expands burial benefits for veterans who die at home while receiving VA hospice care. It adds a new eligibility category allowing burial allowances for veterans who were in VA hospice care at home *only if* they previously received VA hospital or nursing home care. The bill amends existing law to include this scenario under the veterans' burial allowance program. This change directly affects veterans receiving VA hospice care at home after prior VA facility-based care, ensuring they qualify for burial benefits similar to those who die in VA facilities. The policy change takes effect as if included in the 2020 Veterans Health Care Act.
HR 7227, the Mental Health and MAMA Act of 2026, eliminates cost-sharing (like copays or deductibles) for mental health and substance use treatment services during pregnancy and for one year after childbirth. It directly affects pregnant and postpartum individuals covered by group health plans or individual insurance policies, requiring these plans to cover such services with no out-of-pocket costs from pregnancy diagnosis through the 12-month period following birth. The law applies to in-network providers and includes telehealth services, with implementation delayed until two years after enactment. It amends key laws including the Public Health Service Act, ERISA, and the Internal Revenue Code to standardize this coverage requirement across health insurance systems. This policy change aims to improve access to care during a critical health period without altering existing coverage definitions.
HR 7173, the Follow the Science Act, restricts political appointees from influencing National Institutes of Health (NIH) operations and grant decisions. It prohibits most political appointees (defined broadly as those in policy-making roles) from being employed by NIH or participating in grant reviews, funding selections, or policy implementation. The bill requires the NIH Director to report on past political appointee involvement in these activities to Congress within 30 days of enactment. These changes aim to ensure NIH decisions are based on scientific merit rather than political influence, with limited exceptions for other federal agencies.
